Rapid progression of myelofibrosis in polycythemia vera patient carrying SRSF2 c.284C>A p.(Pro95His) and unique ASXL1 splice site c.1720‐2A>G variant

BACKGROUND: The prognosis in polycythemia vera (PV) is comparatively favorable, but individual myelofibrosis/leukemic progression risk is heterogeneous. About a quarter of patients progress to the fibrotic phase after 20 years. METHODS: Multiplex PCR, allele‐specific qPCR, high‐resolution melt analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanduła, Zuzanna, Kroll‐Balcerzak, Renata, Lewandowski, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102755/
https://www.ncbi.nlm.nih.gov/pubmed/35435261
http://dx.doi.org/10.1002/jcla.24388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102755/
https://www.ncbi.nlm.nih.gov/pubmed/35435261
http://dx.doi.org/10.1002/jcla.24388

Ejemplares similares